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Background. Cutaneous leishmaniasis (CL) caused by Leishmania braziliensis remains an important public health problem in Brazil. The goal of this study was to identify genetic risk factors for CL.
Methods. Genome-wide analysis was undertaken using DNAs from 956 CL cases and 868 controls (phase 1) and 1110 CL cases and 1178 controls (phase 2) genotyped using Illumina HumanCoreExome BeadChips. Imputation against 1000G data provided 4,498,586 qualitycontrolled single nucleotide variants (SNVs) common across phase 1 and phase 2 samples.
Linear mixed models in FastLMM were used to take account of genetic diversity/ethnicity/admixture. Cellular cytokines were measured using flow cytometry.
Results. Combined analysis across cohorts found no associations that achieved genome-wide significance, commonly accepted as P<5x10 -8 . Support for variants at wound-healing genes previously studied as candidate genes for CL included SMAD2 (rs115582038/rs75753347; Pimputed_1000G=1.47x10 -4 ). Top novel GWAS hits at P<5x10 -5 in plausible candidate genes for CL included SERPINB10 (rs62097497;Pimputed_1000G=2.67x10 -6 ), CRLF3 (rs75270613;
Pimputed_1000G=5.12x10 -6 ), STX7 (rs144488134;Pimputed_1000G=6.06x10 -6 ), KRT80 (rs10783496 Pimputed_1000G=6.58x10 -6 ), LAMP3 (rs74285558;Pimputed_1000G=6.54x10 -6 ) and IFNG-AS1 (rs4913269;Pimputed_1000G=1.32x10 -5 ). Of these, LAMP3 (Padjusted=9.25x10 -12 ; +6-fold), STX7 (Padjusted=7.62x10 -3 ; +1.3-fold) and CRLF3 (Padjusted=9.19x10 -9 ; +1.97-fold) were all expressed more highly in CL biopsies compared to normal skin, whereas expression of KRT80 (Padjusted=3.07x10 -8 ; -3-fold) was lower. Notably, the percent peripheral blood CD3 
INTRODUCTION
American cutaneous leishmaniasis (ACL) caused by Leishmania braziliensis is associated with a variety of clinical presentations including cutaneous leishmaniasis (CL), mucosal leishmaniasis (ML), and disseminated leishmaniasis (DL). ML and DL are generally preceded by CL. CL is the most common form of disease and is associated with localized skin lesions, mainly ulcers, on exposed parts of the body. Whilst normally self-limiting, the degree of pathology and the rate of healing varies, and the lesions leave life-long scars. Not all individuals infected with Leishmania parasites go on to develop clinical disease.
Subclinical infection is usually associated with a Leishmania-specific cellular immune response, measured traditionally as a positive delayed type hypersensitivity or Montenegro skin test responses in vivo [1, 2] . Stimulation of peripheral blood lymphocytes with Leishmania antigen also results in production of interferon- (IFN-) and tumour necrosis factor (TNF) in individuals with subclinical infection, but at a lower level than observed with clinical CL [2] . In a longitudinal cohort study, IFN- production, mainly by natural killer cells, was associated with protection, but a positive Leishmania-specific skin-test response did not prevent development of disease [3] . Indeed, a positive Leishmania-specific skin-test response has high sensitivity for the diagnosis of CL caused by L. braziliensis [1, 2, 4] .
Immunologically, the different forms of ACL are generally associated with exaggerated cellular immune responses. In CL, there is a direct correlation between the frequency of CD4 + T cells expressing IFN and TNF and the size of ulcer [5] , while levels of these proinflammatory cytokines are higher in ML than CL [6] . The outcome of L. braziliensis infection appears to be determined by a fine balance between the pro-inflammatory cytokines IFN and TNF and anti-inflammatory interleukin-10 (IL-10) [4, 6, 7] .
A major interest has been in determining the extent to which host genetic factors determine these responses. Racial differences, familial clustering and studies in mice all support host genetic control of Leishmania infections (reviewed [8] [9] [10] [11] ). Human familybased genetic epidemiology studies of CL disease caused by the related L. peruviana pathogen were consistent with a gene by environment multifactorial model, with a two-locus model of inheritance providing the best fit to the data [12] . This suggested that major genetic risk factors might readily be found for CL. To date, candidate gene studies [13] [14] [15] [16] [17] [18] [19] [20] [21] undertaken in L. braziliensis endemic regions have demonstrated putative roles for polymorphisms at multiple genes associated with pro-and anti-inflammatory responses (TNFA, SLC11A1, CXCR1, IL6, IL10, CCL2/MCP1) and with wound healing (FLI1, CTGF, TGFBR2, SMAD2, SMAD3, SMAD7, COL1A1) in determining susceptibility to CL or ML disease. This includes susceptibility genes identified from murine studies of leishmaniasis (SLC11A1, FLI1) [15, 16] . Although frequently underpinned by functional data [17] [18] [19] and/or supported by prior immunological studies [22] [23] [24] [25] [26] , these studies have generally lacked statistical power.
Here we set out to perform a well-powered genome-wide association study for CL caused by L. braziliensis. A robust approach incorporating discovery and replication phases was employed using a total sample size across two cohorts that exceeded 2000 CL cases and 2000 controls. No genes/regions achieved genome-wide significance (commonly accepted as P<5x10 -8 [27] [28] [29] ) in a combined analysis. Support was found for the prior hypothesis [14, 21] that variants at wound-healing genes are risk factors for CL, including at SMAD2, SMAD3 and SMAD 7 studied previously and novel associations at SMAD1, SMAD4, SMAD6, SMAD9, TGFBR3, COL11A1 and COL24A1. Top novel GWAS hits at P<5x10 were recorded for all participants. Blood (8 ml) was taken by venipuncture and collected into dodecyl citrate acid (DCA)-containing vacutainers (Becton Dickinson). Genomic DNA was prepared using the proteinase K and salting-out method [31] . DNAs were shipped to UK for genotyping at Cambridge Genomic Services, Department of Pathology, University of Cambridge, UK.
Array Genotyping and Marker QC
DNAs were genotyped on Illumina Infinium HumanCoreExome Beadchip (Illumina Inc., San Diego, CA, USA), which includes probes for 551,004 single nucleotide variants (SNVs), 282,373 of which are genome-wide tag SNVs that represent core content and are highly informative across ancestries, and 268,631 SNVs that are exome-focused markers. All genotyping data and reference panels were analysed using human genome build 37 (hg19).
Individuals were excluded if they had a missing data rate >5%. SNVs were excluded if they had genotype missingness >5%, minor allele frequency (MAF) <0.01, or if they deviated from Hardy-Weinberg equilibrium (HWE; threshold of P<1.0x10 -8 ). This provided a post-QC dataset of 312,503 genotyped SNVs for the 956 CL cases and 868 controls in the phase 1 sample, and 298,919 genotyped SNVs for the 1110 CL cases and 1178 controls in the phase 2 sample. The phase 1 and phase 2 samples had 52% and 81% power, respectively, and the combined sample 99% power, to detect genome wide significance (P<5x10 -8 ) for genetic effects with a disease allele frequency of 0.25, effect size (genotype relative risk) of 1.5, and assuming a disease prevalence of 2%.
SNV Imputation and GWAS
Imputation of missing and non-assayed genetic variants was performed using the 1000 Genomes Project phase 3 reference panel [32] , which contains 84.8 million variants for 2504 samples from 26 populations throughout Africa, America, East Asia, Europe and South-East Asia. The 293,563 post-QC array variants genotyped in common across phase 1 and phase 2 samples were phased and imputed using the Michigan Imputation Server v1.0.4 [33] . We excluded imputed SNVs with an information metric <0.8 or genotype probability <0.9, and the remaining variants were converted to genotype calls and filtered for <5% missingness and MAF>0.005. Imputation accuracy was assessed using the r Genome-wide association analysis for the CL phenotype was performed using a linear mixed model as implemented in FaST-LMM v2.07, which takes account of both relatedness and population substructure and generally assumes an additive model of inheritance [34] .
Population structure and relatedness were controlled using the genetic similarity matrix, computed from 32,696 Phase 1 and 45,569 Phase 2 LD-pruned array variants, and any systematic confounding assessed using quantile-quantile (Q-Q) plots and a test statistic inflation factor (denoted ) calculated in R version 2.15.0 by dividing the median of the observed chi-squared statistics by the median of the theoretical chi-squared distribution.
Genome-wide significance was set at P5x10 -8 [27] [28] [29] . Manhattan plots were generated using the mhtplot() function of 'gap', a genetic analysis package used in R version 3.4.3.
Regional plots of association were created using LocusZoom [35] in which -log10(P-values) were graphed against their chromosomal location. The 32,696 Phase 1 and 45,569 Phase 2 LD-pruned array variants were matched to data from HapMap populations and PCA plots prepared in R.
Expression analysis
We examined RNA expression for genes of interest using data from a published microarray study [36] that compared skin biopsies from CL patients from our study area with biopsies of normal skin from non-endemic unexposed donors (accessed from the GEO database: GSE55664). Between group comparisons were made on log transformed data using the GEO2R tool within the GEO database, with P-values adjusted using the Benjamini and Hochberg false discovery rate.
Antigen-stimulated T cell responses
Peripheral blood mononuclear cells were available for a subset of CL patients used in the present study affording us the opportunity to determine whether antigen stimulated T cell responses differed by IFNG-AS1 genotype. PBMC from previously untreated cutaneous leishmaniasis patients were obtained from heparinized blood by centrifugation over Ficoll.
Cells were stimulated at 1x10 
RESULTS

Characteristics of the Study Population
Basic demographic information (age, sex) for study participants is shown in Table S1 . Cases and controls were well-matched for age and sex overall, the younger age of endemic controls counterbalanced by the older age of blood bank controls. Given ethnic admixture of Brazilian populations it was of interest initially to compare genetic heterogeneity between CL cases and controls, and between the two sources of endemic versus blood bank control samples. PCA plots (Figure 1) show that blood bank controls were generally well matched to endemic controls, with all controls well-matched to cases. There were a small number of outliers in the discovery endemic controls, which also showed greater genetic heterogeneity in the replication sample compared to blood bank controls and cases. 
Genome-wide Association Study
The GWAS was performed in two phases. Manhattan plots for genotyped data for phase 1 and phase 2 are shown in Figure S1 . Quantile-quantile plots ( Figure S2 ) of the observed versus expected -log10 P-values did not show any evidence for systematic bias in either phase 1 or phase 2, with inflation factors λ of 0.998 and 1, respectively. A Manhattan plot for the combined analysis of imputed genotype data is shown in Figure 3 . The top hits did not achieve genome-wide significance, commonly accepted as P<5x10 -8 for GWAS using variants with minor allele frequencies >1% [27] [28] [29] .
Interrogating the GWAS Data in Relation to Previous Candidate Gene Studies
As noted above, previous candidate gene studies attempting to identify genetic risk factors for CL caused by L. braziliensis have typically been small, underpowered family-based or casecontrol studies [13] [14] [15] [16] [17] [18] [19] [20] [21] . We therefore interrogated the GWAS data to determine whether evidence could be found to support the candidacy of these genes. (Table S2 ), wound healing genes that had previously been shown to be associated with CL [14] . The strongest signal was at SMAD2, as indicated by the peak of association at multiple variants observed on the LocusZoom plot across the region ( Figure   4A ). Associations at SMAD3 and SMAD7 (Table S2 ; see also Figure 4A LocusZoom plot that includes SMAD7) were less well-supported. Some evidence for associations at related SMADs was also observed (Table S2) , specifically at SMAD1, SMAD4 (see also Figure 4A ), SMAD6 and SMAD9. The major role for SMAD proteins is to transduce signals from receptors of the transforming growth factor beta (TGF) superfamily. Although no association at P<0.01 was observed at TGFBR2, association (Table S2) at the functionally related gene TGFBR3 ( Figure 4B ) was supported at multiple variants across the gene.
Similarly, associations (Table S2) observed at collagen genes, COL24A1 ( Figure 4C ) and COL11A1 ( Figure 4D ), functionally related to wound healing gene COL1A1 were supported at multiple variants across each gene. Associations were also observed (Table S2) for variants at genes (IL6R and IL10R) encoding receptors for cytokines IL-6 and IL-10 that have previously been shown to be genetically and/or functionally associated with cutaneous forms of disease caused by L. braziliensis [17, 18] . Table S3 provides a full list of hits that were suggestive of association, using a cut-off P<5x10 -5 . Table 1 , Figure 5 and Figure S3 highlight those hits that are of potential functional relevance to CL. Of specific interest are genes, LAMP3 ( Figure 5A ) and STX7 ( Figure 5B ), that play a role in lysosome function. LAMP3 encodes lysosomal associated membrane protein 3, also known as dendritic cell LAMP or DCLAMP. STX7 encodes Syntaxin 7, which plays a role in the ordered fusion of endosomes and lysosomes with phagosomes.
Candidate Top Hits from the GWAS Data
Other genes, KRT80 ( Figure 5C ) and CRLF3 ( Figure S1A ), may relate to perturbations in skin at the site of infection, while SERPINB10 ( Figure S1B ) and IFNG-AS1 ( Figure 5D are shown in Table S3 . Whilst variants in these regions may be true CL susceptibility loci, there is currently no obvious support for their candidacy related to their functions.
Expression Analysis of Novel Candidate Genes Arising from the GWAS
Disease associated SNVs identified through GWAS mostly localize to non-coding sequence [37] and are enriched for expression quantitative trait loci [38, 39] . An initial piece of evidence to support candidacy of variants identified in our GWAS was to determine (a) if they were expressed in skin and/or lesions, and (b) whether their expression in CL lesions was up-or down-regulated relative to expression in normal skin. We therefore interrogated previously published [36] microarray data that had compared RNA from lesions biopsies with RNA from normal skin biopsies ( Figure S4 ). This showed that LAMP3 (Padjusted = 9.25x10 ; +1.97-fold) were all up-regulated in CL biopsies, whereas expression of KRT80 (Padjusted = 3.07x10 -8 ; -3-fold) was down-regulated. Individual variation in expression levels of these genes in lesions from different donors suggests that some additional level of regulated gene expression may exist. SERPINB10 was expressed at very low levels in both normal and lesion biopsy samples. Probes for IFNG-AS1 were not present on the chips used in the published microarray data [36] . Since IFNG-AS1 expression is known to influence IFN- production [ 
DISCUSSION
Results of the GWAS presented here provide the first hypothesis-free insights into genetic risk factors for CL caused by L. braziliensis. Despite prior evidence for genetic regulation of Leishmania infections [8] [9] [10] [11] [12] , and the well-powered phase 1 and phase 2 study undertaken here, no signals of association achieved genome-wide significance generally accepted as 5x10 -8 for this type of GWAS [27] [28] [29] . Nevertheless, interesting novel genetic risk factors were supported by interrogating suggestive associations that achieved P<5x10 -5 , and modest support (P<0.01) was obtained for some previously studied candidate genes for CL.
In relation to previous candidate gene studies, the concept of a role for wound healing genes in contributing to CL [14, 20] was supported by associations at SMAD genes, with the strongest support observed for variants at SMAD2. SMAD proteins transduce signals from receptors of the TGF superfamily. Although we did not replicate our earlier study [14] showing a genetic association with the type II receptor for TGF encoded by TGFBR2, we did see a positive association at TGFBR3 encoding the type III receptor. TGFBR3 is a membrane proteoglycan [40] that often functions as a co-receptor with other TGF receptor superfamily members [41] . Shedding of the ectodomain also produces soluble TGFBR3 which may inhibit TGF signalling [40] . TGF has long been known to play an important role in tissue fibrosis [42] , with abnormal TGF regulation and function implicated in a large number (reviewed [43] ) of fibrotic and inflammatory pathologies. CL lesions are characterised by a combination of inflammatory immune processes and fibrosis [44] . The fibrotic reaction leads to increased production of extracellular matrix proteins including collagens, as well as the activation of local fibroblasts to differentiate into myofibroblasts [45] . TGF stimulates COL11A1 expression in dermal fibroblasts [46] , while novel myofibroblast-specific expression of COL24A1 is a signature of skin wounds [47] . Together with associations at IL6R and IL10R, our GWAS results support the complex interplay between fibrotic and inflammatory processes in determining pathologies associated with CL caused by L. braziliensis.
The benefit of using an unbiased genome-wide approach to identification of genetic risk factors for disease is its ability to highlight novel genes/pathways involved in disease pathogenesis. Two genetic associations were identified which related to intracellular localization of Leishmania parasite in phagolysosomes [48, 49] , namely the associations at LAMP3 and STX7. LAMP3 encodes lysosomal associated membrane protein 3, also known as dendritic cell LAMP or DCLAMP [50] . Expression of DCLAMP increases markedly upon activation of dendritic cells where it localizes to the MHC Class II compartment immediately before the translocation of MHC Class II molecules to the cell surface [50] .
LAMP3 was expressed at much higher levels in RNA from lesion biopsies compared to normal skin, supporting a role for this gene in contributing to disease susceptibility. Since dendritic cells are the most potent antigen-presenting cells that induce primary T-cell responses, it is likely that the influence of variants at LAMP3 will be related to the processing and presentation of Leishmania antigens to T cells. STX7, on the other hand, encodes syntaxin 7 which influences vesicle trafficking to lysosomes, including phagosome-lysosome fusion [51] . Variants at this gene are therefore likely to be influencing the delivery of Leishmania phagosomes to the lysosomal compartment of host macrophages. STX7 was expressed in normal skin with a modest increase in expression in lesion biopsies, again supporting a possible role for this gene in contributing to disease pathology.
Other genes identified included KRT80 and CRLF3 that may relate to perturbations in the skin at the site of infection and/or in the wound healing response. Keratin 80 encoded by KRT80 is a type II epithelial keratin that is an intermediate filament protein responsible for structural integrity of epithelial cells and has biased expression in skin keratinocytes [52] . At the time of infection pathogens invading the skin can cause keratinocytes to produce chemokines which attract monocytes, natural killer cells, T cells, and dendritic cells [53] .
Interestingly, KRT80 and multiple other keratins (KRT77, KRT81, KRT4, KRT39, KRT32, KRT33B; data not shown) were expressed at much lower levels in lesion biopsies compared to normal skin. To what extent this represents a paucity of keratinocytes in lesions, as opposed to specific down regulation of gene expression in keratinocytes within lesions, will require further investigation. Keratinocytes are known to play an important role in wound healing [45] , are potent producers of IL10 and TGF [54] , and have been shown to change to a sclerotic phenotype by gene silencing of Fli1 [55] . Although association of human CL and FLI1 [14, 15] was not replicated here, Fli1 is a confirmed CL susceptibility gene in mice [56] . Hence, our novel associations also continue to focus on molecules and cells involved in wound healing. CRLF3, on the other hand, encodes a member of the cytokine receptor-like factor 3 family which is expressed in normal skin, but shows pathologically enhanced expression in premalignant actinic keratosis and malignant squamous cell carcinoma [57] .
Further work will be required to determine if CRLF3 is similarly dysregulated in CL lesions.
Two further genes, SERPINB10 and IFNG-AS1, are highlighted in relation to more central roles in determining immune responses. Serpin family B member 10 encoded by SERPINB10 is a peptidase inhibitor expressed in bone marrow [58] in haematopoietic cells of the monocytic lineage [59] and is known to inhibit TNF-induced apoptosis [60] . Epithelial SERPINB10 contributes to allergic eosinophilic inflammation [61] , suggesting additional roles for this molecule in immunopathology. However, we found no evidence for expression of SERPINB10 in normal skin or in lesion biopsies, suggesting that a role in determining susceptibility to CL must be at the level of central regulation of haematopoiesis and/or immune responses. IFNG antisense RNA 1 encoded by IFNG-AS1 has been shown to finetune the magnitude of IFN- responses [30] . It is expressed in both mouse and human T helper1 cells and positively regulates Ifng expression [62, 63] . Transient over-expression of Ifng-as1 in mice is associated with increased IFN- and reduced susceptibility to Salmonella enterica [62] . Conversely, deletion of Ifng-as1 in mice compromises host defence against 
CONCLUSIONS
In conclusion, while not achieving genome-wide significance at any loci, our GWAS has provided further support for variants in wound-healing genes as genetic risk factors for CL as well as providing important novel leads to understanding pathogenesis of CL including through the regulation of IFN- responses.
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Figure S4. Expression of novel candidate genes derived from the GWAS data in RNA from biopsies of normal skin from healthy donors compared to biopsies from lesions of CL patients. Data were accessed from the GEO database: GSE55664. 1 Between group comparisons (normal versus lesions) were made on log transformed data using the GEO2R tool within the GEO database, with P-values adjusted using the Benjamini and Hochberg false discovery rate.
